KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Capital Expenditures (2016 - 2026)

Globus Medical filings provide 15 years of Capital Expenditures readings, the most recent being -$69.2 million for Q3 2025.

  • On a quarterly basis, Capital Expenditures fell 34.22% to -$69.2 million in Q3 2025 year-over-year; TTM through Dec 2025 was $13.5 million, a 88.34% decrease, with the full-year FY2025 number at $13.5 million, down 88.34% from a year prior.
  • Capital Expenditures hit -$69.2 million in Q3 2025 for Globus Medical, down from $72.7 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $110.6 million in Q4 2024 to a low of -$69.2 million in Q3 2025.
  • Median Capital Expenditures over the past 5 years was $4.1 million (2022), compared with a mean of $7.8 million.
  • The widest YoY moves for Capital Expenditures: up 9698.67% in 2024, down 8622.98% in 2024.
  • Globus Medical's Capital Expenditures stood at -$35.3 million in 2021, then plummeted by 36.77% to -$48.3 million in 2022, then skyrocketed by 102.34% to $1.1 million in 2023, then soared by 9698.67% to $110.6 million in 2024, then tumbled by 162.56% to -$69.2 million in 2025.
  • The last three reported values for Capital Expenditures were -$69.2 million (Q3 2025), $72.7 million (Q2 2025), and $10.0 million (Q1 2025) per Business Quant data.